Literature DB >> 22024691

Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm.

Eleonor Tiblad1, Marius Kublickas, Gunilla Ajne, The Hung Bui, Sverker Ek, Anita Karlsson, Agneta Wikman, Magnus Westgren.   

Abstract

INTRODUCTION: We present a review of all cases of intravascular transfusions in red cell alloimmunization over a time span of 20 years in Stockholm. The aim of the study is to compare our results with published results from larger centers and to identify areas that can be further improved.
MATERIAL AND METHODS: A retrospective cohort study was conducted of all women treated with intrauterine transfusions due to erythrocyte immunization in our hospital between June 1990 and June 2010. Primary outcome variables were fetal and neonatal survival, procedure-related complications and gestational age at delivery.
RESULTS: A total of 284 intrauterine transfusions were performed in 84 pregnancies, with an overall survival rate of 91.8%. Procedure-related and fatal complications occurred in the present study in 4.9 and 1.4% of fetuses or neonates, respectively. Procedure-related complications were significantly more common in free-loop transfusions than in transfusions in the intrahepatic part of the umbilical vein (OR: 5.4, p = 0.025). There was no significant difference between the intrahepatic and the placental cord insertion route (p = 0.83). Gestational age at first transfusion was significantly associated with an increased risk of a procedure-related complication (OR: 0.8, p = 0.019). Of the live-born infants, 24% of the neonates were born before gestational week 34. DISCUSSION: Our study confirms previous studies demonstrating favorable results with intravascular transfusions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22024691     DOI: 10.1159/000328683

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  8 in total

1.  Perinatal Outcome After Intrauterine Transfusion in Rh Isoimmunized Mothers.

Authors:  Omkar Potdar; Hemraj R Narkhede; Purnima R Satoskar
Journal:  J Obstet Gynaecol India       Date:  2018-04-02

2.  Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.

Authors:  Arwa Z Al-Riyami; Mouza Al-Salmani; Sabria N Al-Hashami; Sabah Al-Mahrooqi; Ali Al-Marhoobi; Sumaiya Al-Hinai; Saif Al-Hosni; Sathiya M Panchatcharam; Zainab A Al-Arimi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-04-04

3.  Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells.

Authors:  Beate Mayer; Larry Hinkson; Wiebke Hillebrand; Wolfgang Henrich; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2018-10-31       Impact factor: 3.747

4.  Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven.

Authors:  S A Pasman; L Claes; L Lewi; D Van Schoubroeck; A Debeer; M Emonds; E Geuten; L De Catte; R Devlieger
Journal:  Facts Views Vis Obgyn       Date:  2015

5.  Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.

Authors:  C Zwiers; I T M Lindenburg; F J Klumper; M de Haas; D Oepkes; I L Van Kamp
Journal:  Ultrasound Obstet Gynecol       Date:  2017-08       Impact factor: 7.299

6.  Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.

Authors:  Eleonor Tiblad; Agneta Taune Wikman; Gunilla Ajne; Agneta Blanck; Yvonne Jansson; Anita Karlsson; Elisabeth Nordlander; Bibi Shassti Holländer; Magnus Westgren
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

7.  The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization.

Authors:  Carolien Zwiers; Dick Oepkes; Enrico Lopriore; Frans J Klumper; Masja de Haas; Inge L van Kamp
Journal:  Prenat Diagn       Date:  2018-09-27       Impact factor: 3.050

8.  Complications of intravascular intrauterine transfusion for Rh alloimmunization.

Authors:  Asma Alkhaibary; Mohannad Ali; Maha Tulbah; Maha Al-Nemer; Rubina M Khan; Maisoon Al Mugbel; Nada Al Sahan; Marwah Mazen Hassounah; Waleed Alshammari; Wesam I Kurdi
Journal:  Ann Saudi Med       Date:  2021-12-02       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.